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Background
Systemic knockout of adipose triglyceride lipase (ATGL),
the rate-limiting enzyme of triglyceride catabolism, results
in a murine phenotype characterized by progressive accu-
mulation of lipids in the heart finally leading to lethal car-
diac dysfunction. Since cardiac and vascular dysfunction
are closely related we investigated endothelium-dependent
and -independent vessel function of ATGL knockout
(ATGL(-/-)) mice. Using mice with cardiomyocyte-
restricted overexpression of ATGL (cardiac-rescued
phenotype;
ATGL(-/-)/MHC-A35) we were able to differentiate
between heart-related and -unrelated effects.
Results
Aortic relaxation studies and Langendorff perfusion
experiments of isolated hearts demonstrated that ATGL
(-/-) mice suffer from pronounced micro- and macrovas-
cular endothelial dysfunction. Experiments with DEA/NO
revealed the functional integrity of the smooth muscle
cell layer. Since loss in vascular reactivity was restored by
~50 % in cardiac-rescued mice, this phenomenon seems
partly a consequence of impaired cardiac contractility.
Biochemical analysis revealed that aortic eNOS protein
was down-regulated by more than 60% in aortas of ATGL
(-/-) mice. As consequence, phosphorylation of VASP at
Ser 239 was almost abolished. Both parameters were
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Figure 1 (A) Aortic relaxation to acetylcholine is blunted in ATGL deficiency and partly recovered in vessels of mice with a cardiac rescued
phenotype. (B) Aortic eNOS expression in downregulated in ATGL deficiency an reversed upon cardiac rescue.
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totally reversed in vessels of cardiac rescued mice. Aortic
expression of eNOS mRNA was not affect in ATGL defi-
ciency excluding a transcriptional mechanism underlying
the observed effect. Total levels of ubiquitinated proteins
(a measure of vascular proteasomal activity) were down-
regulated in ATGL-deficient aortas (~26% compared to
WT controls) and fully recovered upon cardiomyocyte-
restricted overexpression of ATGL.
Conclusion
Endothelial dysfunction in murine ATGL deficiency partly
arises from impaired cardiac contractility and originates
from down-regulation of aortic eNOS presumably due to
activation of the vascular proteasome. Potential heart-
independent mechanisms contributing to the observed
defect are currently investigated.
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